Companies / United Arab Emirates
Neopharma Forms JV With Biocon
January 2007 | Industry NewsUAE-based drugmaker Neopharma has formed a Joint Venture with Indian biotech firm Biocon , in what is being described as a landmark deal for the region. The JV will be the Gulf Co-operation Council (GCC)'s first foray into the private development of biopharmaceutical products. Neopharma's CEO Dr. B.R Shetty is hopeful that the move will be a catalyst for similar initiatives throughout the Middle East and North Africa (MENA).
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.




